Total Payments
$3,009
2024 Payments
$472.07
Companies
34
Transactions
188
Medicare Patients
6,289
Medicare Billing
$813,015
Payment Breakdown by Category
Food & Beverage$2,904 (96.5%)
Education$104.95 (3.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,904 | 186 | 96.5% |
| Education | $104.95 | 2 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $356.92 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $309.93 | 17 | $0 (2024) |
| PFIZER INC. | $305.29 | 43 | $0 (2021) |
| Exact Sciences Corporation | $250.18 | 8 | $0 (2024) |
| Allergan, Inc. | $216.58 | 9 | $0 (2020) |
| Novo Nordisk Inc | $214.03 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $194.75 | 6 | $0 (2024) |
| Lilly USA, LLC | $133.55 | 9 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $130.10 | 17 | $0 (2019) |
| Amgen Inc. | $109.42 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $472.07 | 19 | Bayer Healthcare Pharmaceuticals Inc. ($205.39) |
| 2023 | $382.42 | 19 | Exact Sciences Corporation ($148.78) |
| 2022 | $186.67 | 11 | AstraZeneca Pharmaceuticals LP ($81.02) |
| 2021 | $318.97 | 14 | Astellas Pharma US Inc ($99.95) |
| 2020 | $400.80 | 23 | Novo Nordisk Inc ($136.91) |
| 2019 | $160.31 | 10 | Radius Health, Inc. ($48.89) |
| 2018 | $177.06 | 13 | GlaxoSmithKline, LLC. ($30.25) |
| 2017 | $910.60 | 79 | Allergan Inc. ($187.84) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.24 | General |
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Gastroenterology | ||||||
| 09/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Cardio-renal | ||||||
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Gastroenterology | ||||||
| 07/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $45.14 | General |
| Category: Oncology | ||||||
| 07/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Cardio-renal | ||||||
| 06/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Cardio-renal | ||||||
| 05/03/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Cardio-renal | ||||||
| 04/15/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Diabetes | ||||||
| 04/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Cardio-renal | ||||||
| 03/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: Oncology | ||||||
| 03/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Biological | ||||||
| 02/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Cardio-renal | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.90 | General |
| 12/06/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $35.97 | General |
| Category: Oncology | ||||||
| 11/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Cardio-renal | ||||||
| 11/20/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Endocrinology | ||||||
| 11/07/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Oral Contraceptive | ||||||
| 10/24/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Cardio-renal | ||||||
| 10/04/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,145 | 4,144 | $432,954 | $197,551 |
| 2022 | 23 | 1,299 | 4,317 | $458,954 | $219,831 |
| 2021 | 22 | 2,107 | 4,550 | $396,518 | $165,930 |
| 2020 | 21 | 1,738 | 6,182 | $576,498 | $229,704 |
Total Patients
6,289
Total Services
19,193
Medicare Billing
$813,015
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 281 | 2,415 | $225,803 | $102,380 | 45.3% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 270 | 497 | $98,406 | $46,728 | 47.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 189 | $34,304 | $16,570 | 48.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 43 | $8,845 | $5,383 | 60.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 43 | 43 | $7,332 | $5,363 | 73.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 35 | 151 | $12,458 | $5,266 | 42.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 23 | 97 | $9,603 | $3,368 | 35.1% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 41 | 47 | $9,306 | $2,503 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $6,788 | $2,451 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 36 | $4,215 | $2,017 | 47.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 23 | 54 | $4,752 | $1,551 | 32.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 58 | 131 | $3,603 | $1,247 | 34.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 45 | 45 | $1,584 | $800.10 | 50.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 44 | 44 | $1,549 | $782.32 | 50.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 41 | 45 | $1,998 | $388.98 | 19.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 56 | 75 | $408.75 | $255.75 | 62.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 26 | $1,101 | $234.76 | 21.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 13 | 13 | $286.00 | $210.86 | 73.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 56 | $448.00 | $41.43 | 9.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 112 | $168.00 | $9.41 | 5.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 297 | 2,107 | $197,005 | $100,660 | 51.1% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 307 | 543 | $107,514 | $50,964 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 247 | $44,831 | $21,192 | 47.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 44 | 243 | $24,057 | $9,643 | 40.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 41 | 257 | $21,203 | $9,402 | 44.3% |
About Dr. Dawn Walker, DO
Dr. Dawn Walker, DO is a Family Medicine healthcare provider based in Willcox, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306895529.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dawn Walker, DO has received a total of $3,009 in payments from pharmaceutical and medical device companies, with $472.07 received in 2024. These payments were reported across 188 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,904).
As a Medicare-enrolled provider, Walker has provided services to 6,289 Medicare beneficiaries, totaling 19,193 services with total Medicare billing of $813,015. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Willcox, AZ
- Active Since 05/06/2006
- Last Updated 05/20/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306895529
Products in Payments
- Kerendia (Drug) $356.92
- Cologuard Collection Kit (Device) $250.18
- FARXIGA (Drug) $127.63
- VIBERZI (Drug) $125.23
- FLECTOR (Drug) $114.65
- Ozempic (Drug) $90.84
- RYBELSUS (Drug) $87.83
- BEVESPI AEROSPHERE (Drug) $86.35
- Tymlos (Biological) $76.51
- XARELTO (Drug) $71.67
- JARDIANCE (Drug) $65.92
- TRULICITY (Drug) $63.07
- VRAYLAR (Drug) $59.55
- INVOKANA (Drug) $58.43
- LYRICA (Drug) $57.87
- EMGALITY (Drug) $47.40
- Myrbetriq (Drug) $43.67
- COLOGUARD DNA CAPTURE REAGENTS (Device) $41.09
- Vascepa (Drug) $40.77
- Repatha (Biological) $40.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.